Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicola Ingram

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
Langmuir : the ACS Journal of Surfaces and Colloids|November 2, 2022
The Influence of Nanobubble Size and Stability on Ultrasound Enhanced Drug DeliveryDamien V B Batchelor, Fern J Armistead, Nicola Ingram, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 21, 2020
High-throughput microfluidics for evaluating microbubble enhanced delivery of cancer therapeutics in spheroid culturesMatthew D Bourn, Damien V B Batchelor, Nicola Ingram, et al.
Cancers|October 3, 2020
Translating Biomarkers of Cholangiocarcinoma for Theranosis: A Systematic ReviewImeshi Wijetunga, Laura E McVeigh, Antonia Charalambous, et al.
Nanomedicine (London, England)|February 20, 2015
CEA-targeted nanoparticles allow specific in vivo fluorescent imaging of colorectal cancer modelsJames P Tiernan, Nicola Ingram, Gemma Marston, et al.
Soft Matter|August 9, 2016
The influence of intercalating perfluorohexane into lipid shells on nano and microbubble stabilityRadwa H Abou-Saleh, Sally A Peyman, Benjamin R G Johnson, et al.
Carcinogenesis|June 21, 2013
Reduced type II interleukin-4 receptor signalling drives initiation, but not progression, of colorectal carcinogenesis: evidence from transgenic mouse models and human case-control epidemiological observationsNicola Ingram, Emma L Northwood, Sarah L Perry, et al.
Cancer Chemotherapy and Pharmacology|October 11, 2020
Cyclooxygenase activity mediates colorectal cancer cell resistance to the omega-3 polyunsaturated fatty acid eicosapentaenoic acidMilene Volpato, Nicola Ingram, Sarah L Perry, et al.
Pharmaceutics|March 26, 2022
A Single Short 'Tone Burst' Results in Optimal Drug Delivery to Tumours Using Ultrasound-Triggered Therapeutic MicrobubblesNicola Ingram, Laura E McVeigh, Radwa H Abou-Saleh, et al.
Small (Weinheim an Der Bergstrasse, Germany)|March 8, 2021
Evaluating Phospholipid-Functionalized Gold Nanorods for In Vivo ApplicationsLucien Roach, Mary E Booth, Nicola Ingram, et al.
ACS Applied Materials & Interfaces|February 23, 2022
Affimer Tagged Cubosomes: Targeting of Carcinoembryonic Antigen Expressing Colorectal Cancer Cells Using <i>In Vitro</i> and <i>In Vivo</i> ModelsArindam Pramanik, Zexi Xu, Shazana H Shamsuddin, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Langmuir : the ACS Journal of Surfaces and Colloids|November 2, 2022
The Influence of Nanobubble Size and Stability on Ultrasound Enhanced Drug DeliveryDamien V B Batchelor, Fern J Armistead, Nicola Ingram, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 21, 2020
High-throughput microfluidics for evaluating microbubble enhanced delivery of cancer therapeutics in spheroid culturesMatthew D Bourn, Damien V B Batchelor, Nicola Ingram, et al.
Cancers|October 3, 2020
Translating Biomarkers of Cholangiocarcinoma for Theranosis: A Systematic ReviewImeshi Wijetunga, Laura E McVeigh, Antonia Charalambous, et al.
Nanomedicine (London, England)|February 20, 2015
CEA-targeted nanoparticles allow specific in vivo fluorescent imaging of colorectal cancer modelsJames P Tiernan, Nicola Ingram, Gemma Marston, et al.
Soft Matter|August 9, 2016
The influence of intercalating perfluorohexane into lipid shells on nano and microbubble stabilityRadwa H Abou-Saleh, Sally A Peyman, Benjamin R G Johnson, et al.
Carcinogenesis|June 21, 2013
Reduced type II interleukin-4 receptor signalling drives initiation, but not progression, of colorectal carcinogenesis: evidence from transgenic mouse models and human case-control epidemiological observationsNicola Ingram, Emma L Northwood, Sarah L Perry, et al.
Cancer Chemotherapy and Pharmacology|October 11, 2020
Cyclooxygenase activity mediates colorectal cancer cell resistance to the omega-3 polyunsaturated fatty acid eicosapentaenoic acidMilene Volpato, Nicola Ingram, Sarah L Perry, et al.
Pharmaceutics|March 26, 2022
A Single Short 'Tone Burst' Results in Optimal Drug Delivery to Tumours Using Ultrasound-Triggered Therapeutic MicrobubblesNicola Ingram, Laura E McVeigh, Radwa H Abou-Saleh, et al.
Small (Weinheim an Der Bergstrasse, Germany)|March 8, 2021
Evaluating Phospholipid-Functionalized Gold Nanorods for In Vivo ApplicationsLucien Roach, Mary E Booth, Nicola Ingram, et al.
ACS Applied Materials & Interfaces|February 23, 2022
Affimer Tagged Cubosomes: Targeting of Carcinoembryonic Antigen Expressing Colorectal Cancer Cells Using <i>In Vitro</i> and <i>In Vivo</i> ModelsArindam Pramanik, Zexi Xu, Shazana H Shamsuddin, et al.
Pageof 4